LeMaitre Vascular Balance Sheet Health
Financial Health criteria checks 6/6
LeMaitre Vascular has a total shareholder equity of $331.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $377.0M and $46.0M respectively. LeMaitre Vascular's EBIT is $49.6M making its interest coverage ratio -11.5. It has cash and short-term investments of $123.9M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -11.5x |
| Cash | US$123.89m |
| Equity | US$331.07m |
| Total liabilities | US$45.95m |
| Total assets | US$377.03m |
Recent financial health updates
No updates
Recent updates
LeMaitre Vascular: The Market Is Catching On To This Dividend Growth Story
Nov 03LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Nov 02
Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Potentially Undervalued?
Oct 08Investors Met With Slowing Returns on Capital At LeMaitre Vascular (NASDAQ:LMAT)
Sep 17LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Price In Tune With Earnings
Sep 04If EPS Growth Is Important To You, LeMaitre Vascular (NASDAQ:LMAT) Presents An Opportunity
Aug 22LeMaitre Vascular: A Small Cap With Best-In-Industry Growth
Jul 23Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$85.0 Based On Its Intrinsic Value?
Jul 12Is There Now An Opportunity In LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Jun 18Return Trends At LeMaitre Vascular (NASDAQ:LMAT) Aren't Appealing
Jun 05LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Popularity With Investors Is Clear
May 02Is Now The Time To Put LeMaitre Vascular (NASDAQ:LMAT) On Your Watchlist?
Apr 04Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Feb 29What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?
Jan 19Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Paint A Concerning Picture
Oct 27Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Oct 11Does LeMaitre Vascular (NASDAQ:LMAT) Deserve A Spot On Your Watchlist?
Aug 30The Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Don't Inspire Confidence
Jul 06Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$62.3 Based On Its Intrinsic Value?
May 20Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Mar 12Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Oct 23Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Oct 05LeMaitre Vascular (NASDAQ:LMAT) Could Be Struggling To Allocate Capital
Sep 13LeMaitre Vascular: Reiterate Buy Thesis Following Strong Q2 Numbers
Sep 08LeMaitre Vascular goes ex dividend tomorrow
Aug 23Financial Position Analysis
Short Term Liabilities: LMAT's short term assets ($227.1M) exceed its short term liabilities ($29.3M).
Long Term Liabilities: LMAT's short term assets ($227.1M) exceed its long term liabilities ($16.6M).
Debt to Equity History and Analysis
Debt Level: LMAT is debt free.
Reducing Debt: LMAT had no debt 5 years ago.
Debt Coverage: LMAT has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: LMAT has no debt, therefore coverage of interest payments is not a concern.